Metabolic disorders

Metabolic disorders encompass a broad and heterogeneous group of clinical conditions characterized by the disruption of normal chemical processes that convert food into energy at the cellular level (MedlinePlus, 2023). These conditions may be inherited, such as inborn errors of metabolism like Phenylketonuria, or acquired, such as Metabolic Syndrome and Type 2 Diabetes. The underlying pathology typically involves the dysfunction of specific enzymes, transporters, or hormonal signaling pathways, leading to the toxic accumulation of metabolites or a critical deficiency of essential biological products (NIH, 2022). Because the term 'Metabolic disorders' describes a wide-ranging class of pathological states and disease indications rather than a specific protein, enzyme, or receptor, it is not classified as a discrete therapeutic target. In pharmacological research, drug discovery is directed toward specific molecular targets within these pathways, such as the Glucagon-like peptide 1 (GLP-1) receptor or HMG-CoA reductase, rather than the disease category itself (StatPearls, 2023).

Other names

Metabolic diseasesInborn errors of metabolismMetabolic syndromeDisorders of metabolism

Not applicable; this is a disease category and not a single molecular target.